These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22123154)

  • 21. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic deep brain stimulation for Parkinson's disease: correlation of active contacts and electrophysiologically mapped subthalamic nucleus.
    Zheng Z; Zhang YQ; Li JY; Zhang XH; Zhuang P; Li YJ
    Chin Med J (Engl); 2009 Oct; 122(20):2419-22. PubMed ID: 20079152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson's disease.
    Tabbal SD; Revilla FJ; Mink JW; Schneider-Gibson P; Wernle AR; de Erausquin GA; Perlmutter JS; Rich KM; Dowling JL
    Neurosurgery; 2007 Sep; 61(3 Suppl):119-27; discussion 127-9. PubMed ID: 17876242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electrophysiological study of symptomatic improvement by subthalamic stimulation on patients with Parkinson's disease].
    Tian S; Zhuang P; Li Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3321-4. PubMed ID: 18478943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the variability in the anatomical position and size of the subthalamic nucleus among patients with advanced Parkinson's disease using magnetic resonance imaging.
    Daniluk S; G Davies K; Ellias SA; Novak P; Nazzaro JM
    Acta Neurochir (Wien); 2010 Feb; 152(2):201-10; discussion 210. PubMed ID: 19806309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease.
    Castrioto A; Meaney C; Hamani C; Mazzella F; Poon YY; Lozano AM; Hodaie M; Moro E
    Neurobiol Dis; 2011 Jan; 41(1):131-7. PubMed ID: 20826212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of the subthalamic nucleus: the case for direct MRI guided targeting.
    Ashkan K; Blomstedt P; Zrinzo L; Tisch S; Yousry T; Limousin-Dowsey P; Hariz MI
    Br J Neurosurg; 2007 Apr; 21(2):197-200. PubMed ID: 17453788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional fluid-attenuated inversion recovery sequence for visualisation of subthalamic nucleus for deep brain stimulation in Parkinson's disease.
    Heo YJ; Kim SJ; Kim HS; Choi CG; Jung SC; Lee JK; Lee CS; Chung SJ; Cho SH; Lee GR
    Neuroradiology; 2015 Sep; 57(9):929-35. PubMed ID: 26156865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.